Hope for man’s best friend: Scientists in the US develop breakthrough medication for canine cancer – TheLiberal.ie – Our News, Your Views
April 19, 2018

Hope for man’s best friend: Scientists in the US develop breakthrough medication for canine cancer

According to reports in the US researchers at Colorado State University have potentially found a new cure for canine cancer.

It is understood that top scientists at the university have developed a drug name Tanovea-CA1 that will actively cure canine lymphoma. The new drug which will be available to veterinarians in US will hopefully revolutionise how veterinarians treat dogs with cancer.

It is believed Lymphoma is among the most common forms of cancer in pets, and typically starts in the lymph nodes and other organs of the immune system. The new drug is designed to target and attack cancer cells implicated in lymphoma.

According to Dr. Doug Thamm, a veterinarian and cancer researcher who led clinical trials at CSU’s Flint Animal Cancer Center: “Across the board, we saw some positive activity in up to 80 percent of all the lymphoma patients that were treated with this medication.”

The drug has already proven to be successful after a 9-year-old Golden Retriever from Denver named Dane made a full recovery following extensive treatment. The dog’s recovery was made all the more special given the fact that its owners thought their dog would have to be euthanized because he could no long stand and wouldn’t eat or drink much.

However remarkably after just five months, Dane received his final treatment and his owners said he is doing much better.

It is understood the revolutionary new drug was originally created to treat lymphoma in human patients but never went through the human clinical development stage.

But now it seems the drug has proven effective in the canine world, with treatment consisting of various doses every three weeks with a total of five infusions.

Share this story

Get the latest news from TheLiberal.ie via Facebook.
Just click Like

Tell us what you think on our Facebook page